US Stock MarketDetailed Quotes
ALDX Aldeyra Therapeutics
- 4.949
- +0.249+5.30%
Trading Nov 19 10:58 ET
294.72MMarket Cap-6598P/E (TTM)
5.000High4.640Low178.16KVolume4.640Open4.700Pre Close857.73KTurnover0.41%Turnover RatioLossP/E (Static)59.55MShares6.54852wk High3.46P/B214.10MFloat Cap2.43052wk Low--Dividend TTM43.26MShs Float16.700Historical High--Div YieldTTM7.66%Amplitude1.420Historical Low4.814Avg Price1Lot Size
About Aldeyra Therapeutics Company
Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities with related general business planning, including raising capital. It engages in the discovery of therapies designed to treat immune-mediated diseases. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.
Company Profile
SymbolALDX
Company NameAldeyra Therapeutics
Listing DateMay 2, 2014
Issue Price8.00
Founded2004
CEODr. Todd C. Brady, M.D.,PhD
MarketNASDAQ
Employees10
Fiscal Year Ends12-31
Address131 Hartwell Avenue,Suite 320
CityLexington
ProvinceMassachusetts
CountryUnited States of America
Zip Code02421
Phone1-781-761-4904
Websitehttp://www.aldeyra.com
Company Executives
- Name
- Position
- Salary
- Dr. Todd C. Brady, M.D.,PhD
- Chief Executive Officer, President and Director
- 3.68M
- Dr. Stephen G. Machatha
- Chief Development Officer
- 1.59M
- Michael Alfieri
- Principal Financial Officer and Principal Accounting Officer
- --
- Dr. Richard H. Douglas, PhD
- Chairman of the Board
- 221.98K
- Dr. Neal Walker, D.O.
- Independent Director
- 174.22K
- Dr. Ben Bronstein, M.D.
- Independent Director
- 190.40K
- Dr. Gary M. Phillips, M.D.
- Independent Director
- 194.07K
- Martin J. Joyce
- Independent Director
- 195.66K
- Nancy Miller-Rich
- Independent Director
- 174.22K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
